Bibliometric and visual analysis of research on chemoresistance mechanisms in triple-negative breast cancer, 2015–2025
iCell · 01.11.2024
DOI: 10.71373/tvcy3824 ↗Kurz gefasst
Fachartikel in der Zeitschrift iCell, online erschienen am 01.11.2024. Verfasst von Yifei Chen und 5 weiteren Autor:innen.
Abstract (Originalsprache)
To characterize publication patterns, collaboration networks, and research themes in the literature captured by a predefined search on triple-negative breast cancer (TNBC) chemoresistance. The Web of Science Core Collection (WoSCC) was searched for English-language articles and reviews published from January 1, 2015, to December 8, 2025. The query combined TNBC with cisplatin, paclitaxel, doxorubicin, or gemcitabine and terms related to chemoresistance and mechanisms. After screening, 212 records were analyzed using CiteSpace, VOSviewer, and the bibliometrix R package. Annual output increased from 5 publications in 2015 to 39 in 2025; 92 publications (43.40%) appeared during 2023–2025. China contributed 98 publications (46.23%) but had lower betweenness centrality (0.15) than the United States (0.34) and India (0.28). Oncology and biochemistry and molecular biology were the leading disciplines. Keyword and burst analyses identified persistent attention to chemoresistance, apoptosis, and signaling pathways, with recent activity in proliferation, gene expression, and phosphorylation. Nanomedicine and metabolism appeared as research themes, but the bibliometric data do not establish clinical efficacy. TNBC chemoresistance research develops rapidly. Current studies focus on molecular mechanisms and novel therapies. This study constitutes an exploratory bibliometric analysis based on 212 records from the Web of Science Core Collection; however, it does not represent the entirety of the literature on chemotherapy resistance in TNBC. It is necessary to strengthen international cooperation. Its findings describe research activity rather than treatment effectiveness and should not be generalized to all TNBC systemic therapies.
Zitieren
APA
Chen, Y., Lu, J., Ye, J., Chen, Y., Deng, X., & Zeng, Q. (2024). Bibliometric and visual analysis of research on chemoresistance mechanisms in triple-negative breast cancer, 2015–2025. iCell. https://doi.org/10.71373/tvcy3824
Vancouver
Chen Y, Lu J, Ye J, Chen Y, Deng X, Zeng Q. Bibliometric and visual analysis of research on chemoresistance mechanisms in triple-negative breast cancer, 2015–2025. iCell. 2024. doi:10.71373/tvcy3824
BibTeX
@article{Chen2024,
author = {Chen, Yifei and Lu, Jia and Ye, Junjie and Chen, Yunyi and Deng, Xi and Zeng, Qiyan},
title = {Bibliometric and visual analysis of research on chemoresistance mechanisms in triple-negative breast cancer, 2015–2025},
journal = {iCell},
year = {2024},
doi = {10.71373/tvcy3824}
}
EUVIMED